Sine yesterday at 3pm a transplant marathon. 7 #kidneytransplants in 36 hours. It is a satisfaction, it reminds you how wonderful #urology is. And nothing would be possible without a super team: coordination, efficiency and good spirits. What a weekend!!

Gran reunión, debate interesantíssimo!

In New Orleans with our resident Mònica Peradejordi to present results from Hospital Clínic clinical research in bladder cancer and kidney transplant

#AUA22 Our resident Mònica Peradejordi impressively defending Hospital Clínic results of initial experience with ICG use in RC, moderated by old UrologyMSK friend KATIE MURRAY.

Gracias a ti Dani, siempre es un placer contar contigo en Hospital Clínic

Absolutely wise and clear algorithm on PCa early detection by Renée Hogenhout. #EAU22 European Association of Urology (EAU)

Honoured to work in a department of #Urology ranked among the first in the world.! newsweek.com/rankings/world… Antonio Alcaraz MMusquera JuanMCorral Antoni Vilaseca Hospital Clínic

Demà a les 15h s’inaugura el #25SimposiSCU ! Comencem amb la reunió anual de la GRUC, un simposi sobre tractament de càncer de pròstata avançat, dues sessions de pòsters i una de vídeos. T’hi esperem! Consulta el programa👇

‼️Aquest dijous tornen les sessions ordinàries de la SCU amb una taula sobre Actualització en el Càncer de Pròstata, amb les ponències de Lluís Fumadó, Antoni Vilaseca i francescosanguedolce, moderada per GAYA i Fernando Lozano No us la perdeu!

Phase 1 first-in-human study of intravesical erdafitinib. Promising trial to keep an eye on. Presented at #ASCOGU23. Hospital Clínic ASCO bladder.uroonco.uroweb.org/video/safety-a…

First-in-human study of intravesical erdafitinib for NMIBC in which Hospital Clínic is participating. Team work with Maria J. Ribal Clàudia Mercader Antonio Alcaraz Félix Guerrero-Ramos Fernando Lozano Óscar Rodríguez Faba

FUTuro 2023. Hemos hablado de novedades, de multidisciplinaridad, de técnicas quirúrgicas. Todo en un ambiente inmejorable y rodeados de viejos amigos.

📅 Hoy, por el DÍA EUROPEO DE SALUD PROSTÁTICA, publicamos este vídeo del Dr. Antoni Vilaseca en el que explica las opciones de tratamiento para el cáncer de próstata, destacando los excelentes resultados si se detecta a tiempo, de ahí la importancia del diagnóstico precoz 👇👇

Covered a great session from Antoni Vilaseca check back on onclive.com for our piece on this session! #AUA2024

Antoni Vilaseca presenting updated data on #TAR210 FIH study in patients with #FGFR+ #NMIBC today at #AUA24 ✅90% estimated 12 months RFS in BCG experienced HR NMIBC ✅90% CR in IR NMIBC #BladderCancer Johnson & Johnson Innovation #MyCompany #Erdafitinib

TAR-210 Demonstrates Preliminary Efficacy in FGFR-Altered Non–Muscle-Invasive Bladder Cancer Antoni Vilaseca #oncology #AUA2024 #MedTwitter #blcsm onclive.com/view/tar-210-d…

A new era is coming for the treatment of NMIBC. Don’t miss this updated summary European Urology Oncology authors.elsevier.com/c/1jDEc9Cfv--d…

🧐Interested in how #NMIBC could be managed in the future? Look at our algorithm for IR-NMIBC! 🕵🏼‍♂️Thorough review of new alternatives in EVERY STAGE of NMIBC 📰Out in European Urology Oncology 👓Read it: t.ly/EpX-n 👥Ashish M. Kamat, MD, MBBS Sia Daneshmand, M.D. Antoni Vilaseca Morgan Roupret Shahrokh F. Shariat